-
公开(公告)号:US20250164774A1
公开(公告)日:2025-05-22
申请号:US18949828
申请日:2024-11-15
Applicant: IDEXX Laboratories, Inc.
Inventor: Jeremy Hammond
Abstract: A method for interrogating a sample with a microscopy analyzer is disclosed. The method includes capturing, by an imaging sensor, of the microscopy analyzer, one or more first images, determining a stain intensity, modifying an intensity of a light source of the microscopy analyzer, based at least in part on the determined stain intensity, in response to modifying the intensity of the light source, capturing one or more second images from the imaging sensor, inputting the one or more first images and the one or more second images into one or more machine learning models, identifying, via the one or more machine learning models, one or more characteristics of the one or more first images and the one or more second images, and transmitting instructions that cause a graphical user interface to display a graphical indication of the one or more characteristics.
-
公开(公告)号:USD1068792S1
公开(公告)日:2025-04-01
申请号:US29851739
申请日:2022-08-31
Applicant: IDEXX Laboratories, Inc.
Designer: Suzanne Magoon , Caitlin Robar , Jessica Solomon , Allison Spake
-
公开(公告)号:US20250091044A1
公开(公告)日:2025-03-20
申请号:US18886870
申请日:2024-09-16
Applicant: IDEXX LABORATORIES, INC.
Inventor: Paige Pomeroy , Adam St. Hilaire , Christopher Duffey , Pamela Cacavas
IPC: B01L3/00
Abstract: Highly reflective, low density, permeable spreading layers for the transport, manipulation and analysis of liquid are provided, as well as articles that incorporate one or more of such permeable spreading layers and related methods.
-
公开(公告)号:US12241900B2
公开(公告)日:2025-03-04
申请号:US18432995
申请日:2024-02-05
Applicant: IDEXX LABORATORIES, INC.
Abstract: This invention provides reagents and methods for diagnosing renal disease. Differential levels of inosine metabolite, and proteins: apolipoprotein C-I, apolipoprotein C-II, fibrinogen alpha chain, or fibrinogen A-alpha chain, kininogen, Inter-Alpha Inhibitor H4 (ITIH4), keratin Type I cytoskeletol 10 cystatin A, cystatin B and other polypeptides and fragments thereof provide biomarkers of renal disease and are described herein.
-
公开(公告)号:US20250062025A1
公开(公告)日:2025-02-20
申请号:US18807045
申请日:2024-08-16
Applicant: IDEXX Laboratories, Inc.
Inventor: Jeremy HAMMOND , Mathew Furtney , Carl Ericson , David Steines , Scott Bender
Abstract: Methods and systems for performing diagnosis using patient sample data are described. The method comprises receiving patient sample data at a point of care, analyzing the received patient sample data at the point of care, and evaluating a first result of analyzing the received patient sample data at the point of care to determine whether a criterion for advanced analysis at a central reference laboratory is met. In a case where the criterion for advanced analysis is met, the method further comprises reflexing the received patient sample data to the central reference laboratory for the advanced analysis, receiving, at the point of care, a second result of the advanced analysis from the central reference laboratory, and displaying at least one of the first result or the second result on a display at the point of care.
-
公开(公告)号:US12213454B2
公开(公告)日:2025-02-04
申请号:US17715393
申请日:2022-04-07
Applicant: IDEXX Laboratories, Inc.
Inventor: Phillip G. Shackelford , Nick Meurrier
Abstract: The systems and methods of flexible and customizable wellness program plan for pets through a distribution network connecting pet-owners, manufacturers, clinics and veterinarians, comprising: customizing a wellness plan to include one or more of the following parameters: frequency of services including exams or bloodwork, frequency of products used including vaccinations or preventatives and frequency of payments; customizing payment frequency for veterinarians for services rendered; tracking commissions to manufacturers for products used; tracking profitability for clinics implementing the wellness program; tracking wellness program plan usage by a pet; tracking enrollment and expiry status of a wellness program plan for a pet; dynamically reporting to one or more of the following: manufacturer, clinic, veterinarian or pet-owner.
-
公开(公告)号:US20240355431A1
公开(公告)日:2024-10-24
申请号:US18757823
申请日:2024-06-28
Applicant: IDEXX Laboratories, Inc.
Inventor: Elizabeth Peters , Jeffrey Lott , Matt Spradley , Matt Russell , Tanya Jarosz
Abstract: An example computer-implemented method of increasing veterinary health care compliance includes receiving information indicating that an animal patient concluded a visit at a veterinary practice, in response accessing diagnostic test results for the animal patient, based on the diagnostic test results creating a pet owner profile for an owner of the animal patient, matching the pet owner profile with a stored message and stored information relating to a product associated with recommended treatment for the animal patient, sending an electronic message to a second computing device associated with the owner of the animal patient that includes the stored message and the stored information relating to the product associated with recommended treatment for the animal patient, receiving a report indicating whether the owner of the animal patient obtained the product associated with recommended treatment for the animal patient, and updating the pet owner profile to be indicative of the report.
-
8.
公开(公告)号:US20240311565A1
公开(公告)日:2024-09-19
申请号:US18603653
申请日:2024-03-13
Applicant: IDEXX Laboratories, Inc.
Inventor: Jennifer Braff , Kevin Knight , Katie Goznikar , Sarah Peterson , Kristen Davenport , Zenhwa Ouyang
IPC: G06F40/279 , G16H10/60 , G16H70/20 , G16H70/40
CPC classification number: G06F40/279 , G16H10/60 , G16H70/20 , G16H70/40
Abstract: An example computer-implemented method for identifying biological samples from non-human subjects for testing includes receiving medical information of a non-human subject, receiving test results including a detected characteristic of a component indicative of a condition for a biological sample from the non-human subject, extracting one or more keywords from the medical information by executing a machine-learning natural language processing logic, and determining whether the detected characteristic is outside of a configurable threshold. In response to determining that the detected level is outside of the configurable threshold and based on the keywords being present in the medical information, the method includes generating instructions to retain the biological sample for further testing.
-
公开(公告)号:US20240260545A1
公开(公告)日:2024-08-08
申请号:US18633241
申请日:2024-04-11
Applicant: IDEXX Laboratories, Inc.
Inventor: Matthew H. Myles , Marcus J. Crim , Robert S. Livingston , Cynthia L. Besch-Williford , Kristin S. Riley
CPC classification number: A01K23/005 , A01K1/03
Abstract: Embodiments disclosed are directed to apparatuses, systems, and methods for the collection and sampling of agents (including organisms and pathogens) to determine the health of an animal colony. The apparatus includes a perforated housing that incorporates a collection media. The collection media is configured to collect a sample from a target animal, such as a mouse or rat, through the perforations of the housing when the target animal interacts with the perforated housing. The collected sample may include dust, feces, fur, urine, saliva, or other aspect of the target animal's environment.
-
公开(公告)号:US12031174B2
公开(公告)日:2024-07-09
申请号:US16362478
申请日:2019-03-22
Applicant: IDEXX LABORATORIES, INC.
Inventor: Giosi Farace , Jon Braff , Murthy V S N Yerramilli
IPC: C12Q1/06 , C12Q1/22 , C12Q1/24 , G01N15/02 , G01N15/0227 , G01N33/493 , G01N33/52
CPC classification number: C12Q1/06 , C12Q1/22 , C12Q1/24 , G01N15/0227 , G01N33/493 , G01N33/52 , G01N2015/0294 , G01N2800/26
Abstract: The disclosure relates generally to methods for measuring bacteria in biological samples. More particularly, the disclosure relates to methods for measuring bacteria using an aqueous clearance solution.
-
-
-
-
-
-
-
-
-